Cale D. Fahrenholtz

Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo

Jessica Swanner, Cale D. Fahrenholtz, Iliana Tenvooren et al. · FASEB BioAdvances · 2019 · 104 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Photothermal Therapy of Glioblastoma Multiforme Using Multiwalled Carbon Nanotubes Optimized for Diffusion in Extracellular Space

Brittany N. Eldridge, Brian W. Bernish, Cale D. Fahrenholtz et al. · ACS Biomaterials Science & Engineering · 2016 · 84 citations

Medicine, Oncology, Biomedical Optics +16

Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

Ning Zhao, Stephanie Peacock, Chen Hao Lo et al. · Science Translational Medicine · 2019 · 76 citations · Full text

Medicine, Pharmacology, Urology +16

Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer

Cale D. Fahrenholtz, Ferenc G. Rick, María I. Rodríguez García et al. · Proceedings of the National Academy of Sciences · 2014 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15

Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with Cisplatin

Cale D. Fahrenholtz, Jessica Swanner, Maria Ramirez-Perez et al. · Journal of Nanomaterials · 2017 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17